Search by Algolia
Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
PMV Consumer Acquisition Corp.PMV Consumer Acquisition Corp. Reports $154,066 Net Loss for Fiscal Year 2025
International Stem Cell CORPInternational Stem Cell Corporation Reports $9.1 Million Revenue for Fiscal Year 2025
FIRST KEYSTONE CORPFirst Keystone Corporation Reports $6.15 Million Net Income for Fiscal Year 2025
REX AMERICAN RESOURCES CorpREX American Resources Reports $83M Net Income and $650.5M Revenue for Fiscal Year Ending January 31, 2026
STRATS SM TRUST FOR WAL-MART STORES, INC. SECURITIES, SERIES 2005-4Wal-Mart Reports $611.3 Billion Revenue and $13.7 Billion Net Income for Fiscal Year Ending January 31, 2023
Thayer Ventures Acquisition Corp IIThayer Ventures Acquisition Corp II Reports $3.88 Million Net Income for 2025
STRATS SM TRUST FOR U S CELL CORP SEC SERIES 2004 6STRATS SM Trust Reports 10% Revenue Growth to $166.4 Million for Fiscal Year
Franklin Crypto TrustFranklin Crypto Trust Reports Fiscal Year End Results and ETF Performance
Photozou Holdings, Inc.Photozou Holdings Reports $180,814 Revenue for Fiscal Year Ending November 30, 2024
ELECTRO SENSORS INCElectro-Sensors Reports 8.2% Sales Increase and 12.5% Gross Profit Growth for Fiscal Year 2025
STEELE BANCORP INCSteele Bancorp Reports 111.4% Asset Growth and $22.9 Million Net Income Following NUBC Merger
TechCom, Inc.TechCom, Inc. Reports No Revenue and Net Loss of $53,488 for Fiscal Year 2025
BioScience Health Innovations, Inc.BioScience Health Innovations Reports 208% Revenue Growth to $5.69 Million for Fiscal Year 2025
LINGERIE FIGHTING CHAMPIONSHIPS, INC.Lingerie Fighting Championships Reports 57% Revenue Increase to $208,485 for Fiscal Year 2025
QHSLab, Inc.QHSLab Reports 26.2% Revenue Growth and Net Income Turnaround for Fiscal Year 2025
Tempest Therapeutics, Inc.Tempest Therapeutics Shifts Focus to CAR-T and Small Molecule Programs After Strategic Acquisition
Scienture Holdings, Inc.Scienture Holdings Reports Fiscal Year 2025 Results with Revenue Growth and Strategic Shift
ALLURION TECHNOLOGIES, INC.Allurion Technologies Reports 53% Revenue Decline, Receives FDA Approval for Gastric Balloon System
MeiraGTx Holdings plcMeiraGTx Reports $114.2 Million Net Loss and $81.4 Million Revenue for 2025
Ondas Inc.Ondas Holdings Inc. Reports $50.7 Million Revenue Growth for Fiscal Year 2025
ENTREPRENEUR UNIVERSE BRIGHT GROUPEntrepreneur Universe Bright Group Reports 7.7% Revenue Growth to $5.68 Million for Fiscal Year 2025
Vor Biopharma Inc.Vor Biopharma Reports $696M Net Loss and Focus on Clinical Trials for Autoimmune Diseases
USA Rare Earth, Inc.USA Rare Earth Reports $298.5 Million Net Loss for Fiscal Year 2025 Amid Strategic Acquisitions
Aura Biosciences, Inc.Aura Biosciences Reports $106.2 Million Net Loss for Fiscal Year 2025
Neumora Therapeutics, Inc.Neumora Therapeutics Reports $236.9 Million Net Loss for 2025, Plans Key Program Updates in 2026